Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biomarin Pharmaceuticals
(NQ:
BMRN
)
90.02
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,262,422
Open
90.00
Bid (Size)
80.00 (1)
Ask (Size)
91.00 (1)
Prev. Close
90.02
Today's Range
89.37 - 90.79
52wk Range
73.67 - 99.56
Shares Outstanding
183,352,255
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
August 21, 2024
Via
Benzinga
Beyond The Numbers: 11 Analysts Discuss Biomarin Pharmaceutical Stock
August 20, 2024
Via
Benzinga
Performance
YTD
-8.19%
-8.19%
1 Month
+6.37%
+6.37%
3 Month
+19.20%
+19.20%
6 Month
-1.34%
-1.34%
1 Year
-3.35%
-3.35%
More News
Read More
Palo Alto Networks To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday
August 20, 2024
Via
Benzinga
NASDAQ:BMRN is not too expensive for the growth it is showing.
August 14, 2024
Via
Chartmill
$1000 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today
August 07, 2024
Via
Benzinga
Rare Disease-Focused BioMarin Narrows Sales Focus, Cuts Cost For Hemophilia A Gene Therapy; Lifts Annual Guidance
August 06, 2024
Via
Benzinga
Investors seeking growth at a reasonable cost should explore NASDAQ:BMRN.
July 24, 2024
Via
Chartmill
$1000 Invested In This Stock 20 Years Ago Would Be Worth $16,000 Today
July 16, 2024
Via
Benzinga
Peering Into Biomarin Pharmaceutical's Recent Short Interest
July 04, 2024
Via
Benzinga
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
August 06, 2024
Via
Benzinga
Biomarin Pharmaceutical Analysts Boost Their Forecasts Following Better-Than-Expected Q2 Results
August 06, 2024
Via
Benzinga
BMRN Stock Earnings: Biomarin Pharmaceutical Beats EPS, Beats Revenue for Q2 2024
August 05, 2024
Via
InvestorPlace
A Glimpse Into The Expert Outlook On Biomarin Pharmaceutical Through 10 Analysts
July 22, 2024
Via
Benzinga
$100 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today
July 18, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Biomarin Pharmaceutical
June 27, 2024
Via
Benzinga
Looking Into Biomarin Pharmaceutical's Recent Short Interest
May 28, 2024
Via
Benzinga
NASDAQ:BMRN is not too expensive for the growth it is showing.
May 21, 2024
Via
Chartmill
Investors should take note of NASDAQ:BMRN, a growth stock that remains attractively priced.
July 02, 2024
Via
Chartmill
For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.
June 11, 2024
Via
Chartmill
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
June 07, 2024
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge
June 05, 2024
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
June 04, 2024
Via
Benzinga
BridgeBio Stock Makes A Bullish Move On Dwarfism Treatment Results
June 04, 2024
Via
Investor's Business Daily
Li Auto Was One Of The Worst-Performing Stocks Last Week: Are These 10 Large-Cap Stocks Losers In Your Portfolio? (May 12-May 18, 2024)
May 19, 2024
Via
Benzinga
4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
May 18, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.